Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axcella Health Inc. | 3,048,780 | reported | 13 Oct 2022 | tx 34+26,537,105−10,193,591 |
| Foghorn Therapeutics Inc. | 2,235,468 | reported | 13 Jan 2026 | tx 16+17,145,056−23,169,625 |
| Evelo Biosciences, Inc. | 791,529 | reported | 02 Feb 2021 | tx 4+130,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jan 2026 | GRANT_AWARD | Foghorn Therapeutics Inc. | 1,117,734 | — | deriv |
| 13 Jan 2026 | GRANT_AWARD | Foghorn Therapeutics Inc. | 1,117,734 | — | deriv |
| 13 Jan 2026 | GRANT_AWARD | Foghorn Therapeutics Inc. | 2,235,468 | 6.71 USD | deriv |
| 13 Oct 2022 | PURCHASE | Axcella Health Inc. | 3,048,780 | 1.64 USD | |
| 13 Oct 2022 | PURCHASE | Axcella Health Inc. | 919,111 | 1.64 USD | |
| 13 Oct 2022 | PURCHASE | Axcella Health Inc. | 2,757,333 | 1.64 USD | |
| 13 Oct 2022 | PURCHASE | Axcella Health Inc. | 2,743,902 | 1.64 USD | |
| 13 Oct 2022 | PURCHASE | Axcella Health Inc. | 914,634 | 1.64 USD | |
| 16 Mar 2022 | PURCHASE | Axcella Health Inc. | 1,579,843 | 1.91 USD | first after silence |
| 16 Mar 2022 | PURCHASE | Axcella Health Inc. | 3,791,623 | 1.91 USD | |
| 16 Mar 2022 | PURCHASE | Axcella Health Inc. | 947,905 | 1.91 USD | |
| 02 Feb 2021 | PURCHASE | Evelo Biosciences, Inc. | 9,285 | 15.00 USD | |
| 02 Feb 2021 | PURCHASE | Evelo Biosciences, Inc. | 37,143 | 15.00 USD | |
| 02 Feb 2021 | PURCHASE | Evelo Biosciences, Inc. | 46,429 | 15.00 USD | |
| 02 Feb 2021 | PURCHASE | Evelo Biosciences, Inc. | 37,143 | 15.00 USD | |
| 27 Oct 2020 | PURCHASE | Foghorn Therapeutics Inc. | 50,000 | 16.00 USD | |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 1,801,801 | — | |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 722,320 | — | |
| 27 Oct 2020 | PURCHASE | Foghorn Therapeutics Inc. | 50,000 | 16.00 USD | |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 1,441,441 | — | |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 4,054,054 | — | |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 4,504,504 | — | |
| 27 Oct 2020 | PURCHASE | Foghorn Therapeutics Inc. | 50,000 | 16.00 USD | |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 7,500,000 | — | deriv |
| 27 Oct 2020 | CONVERSION | Foghorn Therapeutics Inc. | 8,333,333 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 16 Mar 2022.